Italian tyre maker Pirelli is in a risky situation after its Chinese leading shareholder Sinochem rejected a proposal by the ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

Novavax today announced that the US Food and Drug Administration (FDA) has approved full licensure for its COVID-19 vaccine, ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

At long last, Novavax has secured a full FDA approval for its protein-based COVID-19 vaccine, though not in the broad ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

The FDA had been on track to grant Novavax full approval – without restrictions ... the vaccine might be associated with some heart conditions. Another required study must assess the benefits ...

The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use to older adults and ...

May 19, 2025 – The FDA has approved the Novavax COVID-19 vaccine ... But people ages 12 to 64 with medical conditions that increase their risk of serious illness from COVID can also get ...

Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at ...

The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA ...